Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1996
08/22/1996DE19605657A1 Proinsulinderivat und Verfahren zur Herstellung von menschlichem Insulin Proinsulin derivative and process for the preparation of human insulin
08/22/1996DE19519717C1 New microorganism DSM 9771 for prepn of L-alpha-amino acids
08/22/1996DE19506887A1 Rapid isolation of genomic DNA and pure total RNA
08/22/1996DE19505645A1 Model for screening cpds. for inhibition of Helicobacter
08/22/1996CA2223125A1 Production of biologically active recombinant bovine follicle stimulating hormone (recbfsh) in the baculovirus expression system
08/22/1996CA2213444A1 Insecticidal toxins from bracon hebetor
08/22/1996CA2213443A1 Insecticidal peptides from spider venom
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213233A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2213178A1 Plasmid-derived type ii restriction-modification systems from lactococcus lactis
08/22/1996CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996CA2213116A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211938A1 Psychrophilic protease and psychrophilic bacteria
08/22/1996CA2211167A1 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitors
08/22/1996CA2211162A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/22/1996CA2188462A1 Method and composition for regulating apoptosis
08/21/1996EP0727497A1 Primers and probes for the detection of HIV
08/21/1996EP0727496A2 DNA polymerases
08/21/1996EP0727490A1 Human-origin prostacyclin synthase
08/21/1996EP0727489A1 DNA sequence coding for an A. thaliana protein with delta-5,7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use
08/21/1996EP0727488A1 Glucan elicitor receptor and dna coding for the same
08/21/1996EP0727487A1 Multiple-tumor aberrant growth genes
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727483A2 Retrovirus of the HIV-group and its application
08/21/1996EP0727223A1 Polyamino acid oligonucleotide carrier
08/21/1996EP0727046A1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
08/21/1996EP0727045A1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
08/21/1996EP0726965A1 Use of antisense oligomers in a process for controlling contamination in nucleic acid amplification reactions
08/21/1996EP0726964A1 Isolation and composition of novel glycosidases
08/21/1996EP0726963A1 $i(CHLAMYDIAE) PROBES FOR USE IN SOLUTION PHASE SANDWICH HYBRIDIZATION ASSAYS
08/21/1996EP0726962A1 Hiv probes for use in solution phase sandwich hybridization assays
08/21/1996EP0726959A1 Identification of dna-damaging substances by means of cell lines capable of overexpressing poly(adp-ribose)-polymerase
08/21/1996EP0726958A1 A new cephalosporin c acylase
08/21/1996EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
08/21/1996EP0726956A1 Novel human transglutaminases
08/21/1996EP0726955A1 Chimeric proteins comprising borrelia polypeptides: uses therefor
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726953A1 Human kunitz-type protease inhibitors
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726951A1 Manufacture and use of polypeptides tagged using binding molecules
08/21/1996EP0726950A1 Helminth parasite antigen with aminopeptidase-like activity
08/21/1996EP0726949A1 Opioid receptor: compositions and methods
08/21/1996EP0726948A1 Method of inducing and maintaining neuronal cells
08/21/1996EP0726947A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
08/21/1996EP0726946A1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
08/21/1996EP0726945A1 B1k CHAIN OF LAMININ AND METHODS OF USE
08/21/1996EP0726944A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
08/21/1996EP0726940A1 Dna encoding triol polyketide synthase
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726912A1 Cd6 ligand
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726906A1 Synthesizing and screening molecular diversity
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation
08/21/1996EP0726708A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof
08/21/1996EP0726701A1 Salicylic acid binding protein
08/21/1996EP0666865A4 Plant fatty acid synthases.
08/21/1996EP0441886B1 Expression and processing of acetylated fgf's in yeast
08/21/1996EP0386228B1 Replicative rna-based amplification/detection systems
08/21/1996EP0309559B1 Method for producing transgenic pigs
08/21/1996CN1129461A Thermodynamics design and use of nucleic acid sequences
08/21/1996CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic
08/21/1996CN1129255A Method for making recombined granular macrophage colony stimulating factor of human body
08/21/1996CN1129224A Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
08/20/1996US5548076 Method of making oligonucleotides, oligonucleoside thiophosphates and oligonucleoside phosphotriesters using H-phosphonate intermediates
08/20/1996US5548075 DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
08/20/1996US5548068 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
08/20/1996US5548061 Human endothelin-3 precursor protein
08/20/1996US5547935 Muteins of human epidermal growth factor exhibiting enhanced binding at low PH
08/20/1996US5547933 Production of erythropoietin
08/20/1996US5547932 Transfection
08/20/1996US5547871 Genetic engineering
08/20/1996US5547870 Oxalate decarboxylate
08/20/1996US5547869 Plasmids
08/20/1996US5547867 Cultivating host cell under controlled ph and temperature conditions
08/20/1996US5547864 Having cell aggregating property; efficient production of proteins, amino acids, nucleic acids
08/20/1996US5547862 For in vitro synthesis of rna
08/20/1996US5547861 Detection of nucleic acid amplification
08/20/1996US5547859 Chain-terminating nucleotides for DNA sequencing methods
08/20/1996US5547858 Method for purification of amino acids, nucleic acids using a hydrocyclone
08/20/1996US5547856 Hepatocyte growth factor variants
08/20/1996US5547855 Kainate-binding human CNS glutamate receptors EAA3C and EAA3D, DNA encoding them, and expression of the DNA in transformed cells
08/20/1996US5547854 DNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methods
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547852 Composition containing the P40 subunit of interleukin-12
08/20/1996US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16
08/20/1996US5547845 Cloned genes
08/20/1996US5547835 Using the sanger sequencing strategy and assembling the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses
08/20/1996US5547670 Polypeptides
08/20/1996US5547669 Isolated peptide comprising regions having human t-cell stimulating activity, each comprising t-cell epitope of protein allergen arranged in configuration different from that occuring naturally
08/20/1996US5547664 Expression of recombinant proteins in attenuated bacteria
08/20/1996US5547467 Method for measuring a blood component content of blood